Publications by authors named "B Oosterhuis"

Claim this Profile
A
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
Marc Bifano, Carey Hwang, Berend Oosterhuis, Jan Hartstra, Dennis Grasela

Antivir Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.
Walter Brand, Berend Oosterhuis, Peter Krajcsi, Denis Barron, Fabiola Dionisi

Biopharm Drug Dispos· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Graham Lappin, Yoko Shishikura, Roeline Jochemsen, Richard John Weaver, Charlotte Gesson, Berend Oosterhuis

Eur J Pharm Sci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase.
Monika Malm-Erjefält, Inga Bjørnsdottir, Jan Vanggaard, Hans Helleberg, Uffe Larsen, Berend Oosterhuis

Drug Metab Dispos· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
Berend Oosterhuis

Bioanalysis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis